- Home
- NRDY vs MRSN Comparison
NRDY vs MRSN Comparison
Compare NRDY & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- MRSN
- Stock Information
- Founded
- NRDY 2007
- MRSN 2001
- Country
- NRDY United States
- MRSN United States
- Employees
- NRDY N/A
- MRSN N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- NRDY Technology
- MRSN Health Care
- Exchange
- NRDY Nasdaq
- MRSN Nasdaq
- Market Cap
- NRDY 155.4M
- MRSN 138.6M
- IPO Year
- NRDY N/A
- MRSN 2017
- Fundamental
- Price
- NRDY $1.26
- MRSN $27.71
- Analyst Decision
- NRDY Hold
- MRSN Buy
- Analyst Count
- NRDY 3
- MRSN 5
- Target Price
- NRDY $1.25
- MRSN $30.38
- AVG Volume (30 Days)
- NRDY 807.2K
- MRSN 234.8K
- Earning Date
- NRDY 11-06-2025
- MRSN 11-14-2025
- Dividend Yield
- NRDY N/A
- MRSN N/A
- EPS Growth
- NRDY N/A
- MRSN N/A
- EPS
- NRDY N/A
- MRSN N/A
- Revenue
- NRDY $177,867,000.00
- MRSN $33,180,000.00
- Revenue This Year
- NRDY $3.34
- MRSN N/A
- Revenue Next Year
- NRDY $10.69
- MRSN N/A
- P/E Ratio
- NRDY N/A
- MRSN N/A
- Revenue Growth
- NRDY N/A
- MRSN N/A
- 52 Week Low
- NRDY $0.77
- MRSN $5.21
- 52 Week High
- NRDY $2.18
- MRSN $70.73
- Technical
- Relative Strength Index (RSI)
- NRDY 71.16
- MRSN 86.82
- Support Level
- NRDY $0.80
- MRSN $27.15
- Resistance Level
- NRDY $0.88
- MRSN $27.79
- Average True Range (ATR)
- NRDY 0.09
- MRSN 0.65
- MACD
- NRDY 0.05
- MRSN 0.86
- Stochastic Oscillator
- NRDY 96.97
- MRSN 97.27
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.